Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519250 | PMC |
http://dx.doi.org/10.36660/abc.20230533 | DOI Listing |
Healthcare (Basel)
December 2024
Academic-Practice-Partnership of Bern University of Applied Sciences and Insel Gruppe, Bern University Hospital, 3008 Bern, Switzerland.
Background/objectives: Patients requiring haemodialysis often perceive the cost of their travels to the dialysis centres as a significant burden. The study aimed to collect a first Swiss national data set on transport costs and assess their impact on patients and their relatives.
Methods: In addition to interviews with patients, a quantitative survey was developed and distributed online using a voluntary sampling strategy.
Mol Cell Biochem
January 2025
Department of Urology, Guizhou Provincial People's Hospital, Guiyang, 550002, China.
Selenium, an essential trace mineral for health, has seen a rise in clinical trials over the past nearly 5 decades. Our aim here is to provide a comprehensive and concise overview of selenium clinical trials from 1976 to 2023. Overall, the evolution of selenium clinical trials over 48 years has advanced through phases of emergence, prosperity, and either stability or transition.
View Article and Find Full Text PDFInt J Health Plann Manage
December 2024
Centre for Global Chronic Conditions, London School of Hygiene & Tropical Medicine, London, UK.
Background: Reducing inequities in hypertension control among those affected in low- and middle-income countries requires person-centred health system responses based on a contextualised understanding of the choices and care pathways taken by those who rely on the services provided, particularly those from poor and marginalised communities. We examine patterns of care seeking and pathways followed by individuals with hypertension from low-income households in the Philippines and Malaysia. This study aims to fill a significant gap in the literature by analysing the stages at which individuals make decisions that may affect the successful control of their blood pressure.
View Article and Find Full Text PDFInt J Cardiol Congenit Heart Dis
September 2024
National Pulmonary Hypertension Centre, Royal Papworth Hospital, UK.
Chronic thromboembolic pulmonary disease (CTEPD) with or without pulmonary hypertension (PH) occurs when thromboemboli in pulmonary arteries fail to resolve completely. Pulmonary artery obstructions due to chronic thrombi and secondary microvasculopathy can increase pulmonary arterial pressure and resistance leading to chronic thromboembolic PH (CTEPH). Mechanical interventions and/or PH medications can improve cardiopulmonary haemodynamic, alleviate symptoms, and decrease mortality risk.
View Article and Find Full Text PDFClin Kidney J
November 2024
Department of Nephrology and Hypertension, RWTH University Hospital, Aachen, Germany.
Patients with chronic kidney disease are frequently facing the challenge of weight reduction. Finding a weight loss strategy is on the one hand essential to reduce the co-morbidity risks in CKD but remains complex due to the metabolic abnormalities with declining renal function. Here, we provide ten tips to support our CKD patients on their journey, focussing on dietary and behavioural habits and health professional supportive therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!